Valuation: Divi's Laboratories Limited

Market Cap 2,27700Cr 2.39TCr 2.07TCr 1.94TCr 1.77TCr 3.33TCr 3.38TCr 23TCr 8.9TCr 1,14000Cr 8.96TCr 8.77TCr 3,80300Cr P/E 2027 *
70x
P/E 2028 * 58x
Enterprise Value 2,24200Cr 2.35TCr 2.04TCr 1.91TCr 1.74TCr 3.27TCr 3.33TCr 22TCr 8.76TCr 1,12200Cr 8.83TCr 8.63TCr 3,74400Cr EV / Sales 2027 *
17.8x
EV / Sales 2028 * 14.9x
Free-Float
48%
Yield 2027 *
0.41%
Yield 2028 * 0.45%
1 day+0.25%
1 week+2.53%
Current month+6.75%
1 month+23.95%
3 months+29.44%
6 months+39.05%
Current year+34.53%
1 week 8,233.5
Extreme 8233.5
8,674
1 month 6,786.5
Extreme 6786.5
8,674
Current year 5,647.5
Extreme 5647.5
8,674
1 year 5,636.5
Extreme 5636.5
8,674
3 years 3,295.3
Extreme 3295.3
8,674
5 years 2,730
Extreme 2730
8,674
10 years 532.65
Extreme 532.65
8,674
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+2.53%+44.27%+130.53% 2.39TCr
-1.37%+8.90%+91.28%+130.00% 1,08300Cr
-0.77%+1.91%+49.46%+49.44% 63TCr
+0.85%+2.58%+25.90%+64.34% 44TCr
-1.64%-0.44%+47.36%+37.10% 36TCr
-1.73%-0.64%+28.50%+36.01% 29TCr
-1.21%-2.78%+5.55%+5.29% 25TCr
-0.70%+6.23%+45.32%+57.82% 22TCr
-3.30%+1.05%-7.21%-51.98% 21TCr
+2.04%+0.38%+12.70%+69.71% 17TCr
Average -0.63%+2.83%+34.31%+52.83% 36.83TCr
Weighted average by Cap. -0.57%+4.28%+48.89%+65.84%

Financials

2027 *2028 *
Net sales 13TCr 131.75Cr 114.18Cr 106.89Cr 98Cr 183.53Cr 186.61Cr 1.25TCr 491.05Cr 6.29TCr 494.69Cr 483.91Cr 21TCr 15TCr 157.15Cr 136.19Cr 127.49Cr 116.33Cr 218.91Cr 222.59Cr 1.49TCr 585.72Cr 7.5TCr 590.05Cr 577.2Cr 25TCr
Net income 3.26TCr 34Cr 30Cr 28Cr 25Cr 48Cr 48Cr 324.83Cr 127.27Cr 1.63TCr 128.21Cr 125.42Cr 5.44TCr 3.94TCr 41Cr 36Cr 33Cr 31Cr 57Cr 58Cr 392.62Cr 153.83Cr 1.97TCr 154.97Cr 151.59Cr 6.57TCr
Net Debt -3.5TCr -37Cr -32Cr -30Cr -27Cr -51Cr -52Cr -349.07Cr -136.77Cr -1.75TCr -137.78Cr -134.78Cr -5.84TCr -4.49TCr -47Cr -41Cr -38Cr -35Cr -66Cr -67Cr -447.35Cr -175.27Cr -2.25TCr -176.57Cr -172.72Cr -7.49TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
12/26/12 8,600.00 +0.25% 5,59,195
11/26/11 ₹8,578.50 +3.36% 6,03,820
10/26/10 ₹8,300.00 +0.30% 3,79,960
07/26/07 ₹8,275.00 -0.89% 2,56,657
06/26/06 ₹8,349.00 -0.46% 3,27,434
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,578.50INR
Average target price
8,292.48INR
Spread / Average Target
-3.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock